Skip to content

Clinical Trial on Innovative Sthanik Basti instrument

Development and Validation of Innovative Sthanika Basti Instrument- A Pilot Study - NIL

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067081
Enrollment
30
Registered
2024-05-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

None listed

Sponsors

CCRAS Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients indicated for Kati Basti. 2. Patients who are willing to participate in the trial and ready to give written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who are not willing to participate in a trial and not ready to give written informed consent. 2. Patients contraindicated for Sthanika Basti. 3. Patients with Neuropathy. 4. Any other patient that the physician feels should not be included at that point of recruitment considering the clinical scenario. 5. Patients less than the age of 18 years and above 60 years.

Design outcomes

Primary

MeasureTime frame
Validation and ease of use of innovative basti instrumentTimepoint: o,3,7 day

Secondary

MeasureTime frame
Effectiveness of innovative instrument in comparison to traditional methodTimepoint: 0,3,7 day

Countries

India

Contacts

Public ContactDr Komal Sidana

Government Ayurved College, Nagpur

amitnakanekar@gmail.com9511605385

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026